334 related articles for article (PubMed ID: 19914319)
21. Blood-brain barrier and neuro-AIDS.
Zhang YL; Ouyang YB; Liu LG; Chen DX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4927-39. PubMed ID: 26744885
[TBL] [Abstract][Full Text] [Related]
22. Targeting anti-HIV drugs to the CNS.
Rao KS; Ghorpade A; Labhasetwar V
Expert Opin Drug Deliv; 2009 Aug; 6(8):771-84. PubMed ID: 19566446
[TBL] [Abstract][Full Text] [Related]
23. Investigational protease inhibitors as antiretroviral therapies.
Midde NM; Patters BJ; Rao P; Cory TJ; Kumar S
Expert Opin Investig Drugs; 2016 Oct; 25(10):1189-200. PubMed ID: 27415449
[TBL] [Abstract][Full Text] [Related]
24. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
[TBL] [Abstract][Full Text] [Related]
26. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology and the treatment of HIV infection.
Parboosing R; Maguire GE; Govender P; Kruger HG
Viruses; 2012 Apr; 4(4):488-520. PubMed ID: 22590683
[TBL] [Abstract][Full Text] [Related]
28. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
29. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery.
Takalani F; Kumar P; Kondiah PPD; Choonara YE; Pillay V
Pharm Dev Technol; 2020 Mar; 25(3):267-280. PubMed ID: 31744408
[TBL] [Abstract][Full Text] [Related]
30. Towards nanomedicines for neuroAIDS.
Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
[TBL] [Abstract][Full Text] [Related]
31. [Significant role of poloxamer in drug transport across blood-brain barrier].
Zhang W; Fang XL
Yao Xue Xue Bao; 2008 Sep; 43(9):890-7. PubMed ID: 19048778
[TBL] [Abstract][Full Text] [Related]
32. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
[TBL] [Abstract][Full Text] [Related]
33. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
[TBL] [Abstract][Full Text] [Related]
34. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
Khan T; Mayuresh Patkar M; Momin M; Omri A
Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
[TBL] [Abstract][Full Text] [Related]
35. Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
Mahajan SD; Roy I; Xu G; Yong KT; Ding H; Aalinkeel R; Reynolds J; Sykes D; Nair BB; Lin EY; Prasad PN; Schwartz SA
Curr HIV Res; 2010 Jul; 8(5):396-404. PubMed ID: 20426757
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain.
Guo P; Si M; Wu D; Xue HY; Hu W; Wong HL
J Control Release; 2020 Dec; 328():696-709. PubMed ID: 33010335
[TBL] [Abstract][Full Text] [Related]
37. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
38. Impact of ATP-binding cassette transporters on human immunodeficiency virus therapy.
Weiss J; Haefeli WE
Int Rev Cell Mol Biol; 2010; 280():219-79. PubMed ID: 20797684
[TBL] [Abstract][Full Text] [Related]
39. Drug uptake transporters in antiretroviral therapy.
Minuesa G; Huber-Ruano I; Pastor-Anglada M; Koepsell H; Clotet B; Martinez-Picado J
Pharmacol Ther; 2011 Dec; 132(3):268-79. PubMed ID: 21816170
[TBL] [Abstract][Full Text] [Related]
40. Nanotherapeutics: emerging competent technology in neuroAIDS and CNS drug delivery.
Saxena SK; Tiwari S; Nair MP
Nanomedicine (Lond); 2012 Jul; 7(7):941-4. PubMed ID: 22846087
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
